Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Monitored issues related to Pediatric Review Vouchers; 21cc & Innovation Initiative; and S. 2689 the REGROW Act.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES EMILY PORTER